Background
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is an Israeli multinational pharmaceutical company that focuses primarily on production of generic drugs. The company’s global dominance is clear as their healthcare solutions are used by over 200 million patients a day! Teva is truly the world’s largest generic medicines producer.
This reputation has been forged by Teva’s announcement of its $40.5 billion acquisition of Allergan Generics in July 2015. That’s around the time when Teva peaked in stock price, before experiencing a gradual decline in price.
(Figure 1 – Source: Tradingview)
